A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days
- 13 October 2013
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 19 (11) , 1542-1546
Abstract
Antigen-specific T cell therapy, or T cell receptor (TCR) gene therapy, is a promising immunotherapy for infectious diseases and cancers. However, a suitable rapid and direct screening system for antigen-specific TCRs is not available. Here, we report an efficient cloning and functional evaluation system to determine the antigen specificity of TCR cDNAs derived from single antigen-specific human T cells within 10 d. Using this system, we cloned and analyzed 380 Epstein-Barr virus–specific TCRs from ten healthy donors with latent Epstein-Barr virus infection and assessed the activity of cytotoxic T lymphocytes (CTLs) carrying these TCRs against antigenic peptide–bearing target cells. We also used this system to clone tumor antigen–specific TCRs from peptide-vaccinated patients with cancer. We obtained 210 tumor-associated antigen–specific TCRs and demonstrated the cytotoxic activity of CTLs carrying these TCRs against peptide-bearing cells. This system may provide a fast and powerful approach for TCR gene therapy for infectious diseases and cancers.Keywords
This publication has 25 references indexed in Scilit:
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinomaHepatology, 2011
- Paired analysis of TCRα and TCRβ chains at the single-cell level in miceJournal of Clinical Investigation, 2011
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenBlood, 2009
- Comprehensive analysis of the functional TCR repertoire at the single-cell levelBiochemical and Biophysical Research Communications, 2008
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma†Hepatology, 2006
- A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein PeptidesClinical Cancer Research, 2006
- Identification of α‐fetoprotein‐derived peptides recognized by cytotoxic T lymphocytes in HLA‐A24+ patients with hepatocellular carcinomaInternational Journal of Cancer, 2005
- Plat-E: an efficient and stable system for transient packaging of retrovirusesGene Therapy, 2000